WEBSITE BSE:543266 NSE : HERANBA 23 Mar, 16:01
Market Cap ₹1199 Cr.
Stock P/E 8.2
P/B 1.5
Current Price ₹299.6
Book Value ₹ 200.6
Face Value 10
52W High ₹678
Dividend Yield 0.67%
52W Low ₹ 294.8
Heranba Industries Ltd manufactures and markets a number of agrochemicals in India. The employer engages in the research and development, manufacturing, advertising, and distribution of a number of crop safety chemical substances, public fitness, and animal health solutions. It offers numerous pesticides, together with pesticides, herbicides, fungicides, and public health merchandise for pest control. It additionally provides plant growth products, which include amino acids, silicon spreader, gibberellic acid 0.001percent L, and seaweed extracts. In addition, the employer exports its merchandise to approximately 60 nations. The company was formerly known as Heranba Industrial Chemicals Ltd and changed its name to Heranba Industries Ltd in July 1996. Heranba Industries Ltd incorporated in 1992 and is founded in Mumbai, India.
₹ | |
#(Fig in Cr.) | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 |
---|---|---|---|---|---|---|---|
Net Sales | 268 | 351 | 353 | 395 | 362 | 423 | 280 |
Other Income | 5 | 4 | 5 | 5 | 4 | 4 | 1 |
Total Income | 273 | 356 | 359 | 401 | 366 | 427 | 281 |
Total Expenditure | 210 | 287 | 292 | 324 | 316 | 357 | 255 |
Operating Profit | 63 | 69 | 66 | 76 | 51 | 70 | 26 |
Interest | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
Depreciation | 4 | 4 | 4 | 4 | 5 | 6 | 6 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 58 | 64 | 61 | 71 | 44 | 63 | 18 |
Provision for Tax | 15 | 17 | 16 | 18 | 11 | 16 | 4 |
Profit After Tax | 43 | 47 | 46 | 53 | 34 | 48 | 14 |
Adjustments | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
Profit After Adjustments | 43 | 47 | 46 | 53 | 34 | 48 | 14 |
Adjusted Earnings Per Share | 10.8 | 11.8 | 11.4 | 13.4 | 8.4 | 11.9 | 3.6 |
#(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 244 | 340 | 456 | 520 | 520 | 582 | 741 | 1004 | 951 | 1219 | 1450 | 1460 |
Other Income | 7 | 2 | 5 | 8 | 6 | 3 | 5 | 7 | 17 | 7 | 19 | 14 |
Total Income | 251 | 342 | 461 | 527 | 527 | 585 | 747 | 1012 | 968 | 1226 | 1470 | 1475 |
Total Expenditure | 224 | 309 | 419 | 479 | 480 | 535 | 653 | 873 | 822 | 997 | 1191 | 1252 |
Operating Profit | 27 | 33 | 41 | 48 | 46 | 50 | 93 | 139 | 146 | 228 | 279 | 223 |
Interest | 12 | 12 | 13 | 14 | 13 | 12 | 12 | 11 | 9 | 5 | 4 | 6 |
Depreciation | 3 | 3 | 5 | 5 | 4 | 4 | 5 | 6 | 8 | 15 | 20 | 21 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 11 | 17 | 24 | 29 | 29 | 33 | 76 | 122 | 129 | 208 | 255 | 196 |
Provision for Tax | 5 | 8 | 7 | 11 | 12 | 14 | 29 | 47 | 31 | 54 | 66 | 49 |
Profit After Tax | 6 | 9 | 16 | 18 | 17 | 19 | 47 | 75 | 98 | 154 | 189 | 149 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
Profit After Adjustments | 6 | 9 | 16 | 18 | 17 | 19 | 47 | 75 | 97 | 154 | 189 | 149 |
Adjusted Earnings Per Share | 0 | 0 | 0 | 4.8 | 4.3 | 0 | 0 | 0 | 25 | 38.5 | 47.3 | 37.3 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 19% | 13% | 20% | 20% |
Operating Profit CAGR | 22% | 26% | 41% | 26% |
PAT CAGR | 23% | 36% | 58% | 41% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -54% | NA% | NA% | NA% |
ROE Average | 30% | 34% | 35% | 28% |
ROCE Average | 39% | 42% | 44% | 34% |
#(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 43 | 52 | 68 | 85 | 99 | 116 | 157 | 228 | 321 | 528 | 714 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 6 | 6 | 8 | 11 | 8 | 9 | 10 | 9 | 14 | 13 |
Total Current Liabilities | 127 | 163 | 228 | 253 | 237 | 197 | 284 | 322 | 295 | 300 | 339 |
Total Liabilities | 176 | 221 | 302 | 347 | 347 | 321 | 450 | 560 | 625 | 842 | 1066 |
Fixed Assets | 26 | 26 | 37 | 41 | 41 | 38 | 46 | 51 | 95 | 133 | 193 |
Other Non-Current Assets | 5 | 8 | 3 | 2 | 7 | 17 | 30 | 58 | 58 | 41 | 34 |
Total Current Assets | 144 | 187 | 263 | 303 | 300 | 266 | 374 | 452 | 471 | 668 | 839 |
Total Assets | 176 | 221 | 302 | 347 | 347 | 321 | 450 | 560 | 625 | 842 | 1066 |
#(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 7 | 5 | 7 | 8 | 14 | 11 | 10 | 12 | 21 | 3 | 85 |
Cash Flow from Operating Activities | 18 | 5 | 28 | 17 | 16 | 30 | 52 | 88 | 54 | 60 | 98 |
Cash Flow from Investing Activities | -16 | -17 | -23 | -23 | -19 | -6 | -25 | -37 | -52 | -41 | -82 |
Cash Flow from Financing Activities | -4 | 13 | -4 | 12 | 5 | -25 | -26 | -41 | -20 | 62 | -6 |
Net Cash Inflow / Outflow | -2 | 2 | 1 | 6 | 2 | -1 | 1 | 9 | -18 | 82 | 10 |
Closing Cash & Cash Equivalent | 5 | 7 | 8 | 14 | 16 | 10 | 12 | 21 | 3 | 85 | 95 |
# | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.65 | 2.46 | 4.21 | 4.79 | 4.27 | 4.86 | 12 | 19.31 | 25 | 38.54 | 47.25 |
CEPS(Rs) | 2.47 | 3.25 | 5.38 | 6.17 | 5.29 | 5.88 | 13.29 | 20.83 | 27.1 | 42.21 | 52.19 |
DPS(Rs) | 2.5 | 2 | 2.5 | 2.3 | 2.8 | 1.5 | 5.5 | 1 | 1 | 1.7 | 2 |
Book NAV/Share(Rs) | 9.69 | 11.99 | 15.96 | 20.19 | 23.77 | 29.71 | 40.28 | 58.42 | 82.15 | 131.99 | 178.56 |
Core EBITDA Margin(%) | 7.79 | 8.62 | 7.76 | 7.6 | 7.36 | 7.74 | 11.79 | 13.08 | 12.86 | 17.03 | 16.96 |
EBIT Margin(%) | 9.23 | 8.34 | 7.77 | 8.05 | 7.81 | 7.49 | 11.83 | 13.23 | 13.69 | 16.44 | 16.93 |
Pre Tax Margin(%) | 4.45 | 4.85 | 4.99 | 5.47 | 5.35 | 5.46 | 10.24 | 12.16 | 12.81 | 16.02 | 16.67 |
PAT Margin (%) | 2.44 | 2.64 | 3.43 | 3.44 | 3.08 | 3.12 | 6.29 | 7.51 | 9.71 | 11.86 | 12.35 |
Cash Profit Margin (%) | 3.66 | 3.49 | 4.39 | 4.43 | 3.81 | 3.78 | 6.96 | 8.1 | 10.52 | 12.99 | 13.64 |
ROA(%) | 3.47 | 4.73 | 6.19 | 5.67 | 4.81 | 5.68 | 12.15 | 14.92 | 16.48 | 21.03 | 19.82 |
ROE(%) | 18.78 | 22.82 | 30.23 | 26.48 | 19.6 | 18.16 | 34.3 | 39.12 | 35.57 | 36.33 | 30.43 |
ROCE(%) | 23.35 | 26.15 | 28.13 | 28.48 | 23.89 | 23.39 | 40.6 | 51.94 | 42.89 | 45.35 | 38.56 |
Receivable days | 79.67 | 73.45 | 74.96 | 74.17 | 86.81 | 80.88 | 80.14 | 82.92 | 92.84 | 84.27 | 89.54 |
Inventory Days | 96.42 | 70.3 | 63.11 | 69.19 | 62.72 | 52.97 | 47.11 | 37.77 | 47.06 | 43.74 | 50.26 |
Payable days | 111.67 | 83.26 | 103.66 | 121.94 | 106.68 | 82.39 | 99.7 | 108.18 | 128.17 | 95.53 | 86.06 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.39 | 12.79 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.78 | 3.39 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.27 | 0.33 |
EV/Net Sales(x) | 0.26 | 0.22 | 0.16 | 0.16 | 0.17 | 0.14 | 0.1 | 0.07 | 0.08 | 2.03 | 1.62 |
EV/Core EBITDA(x) | 2.39 | 2.33 | 1.72 | 1.69 | 1.89 | 1.66 | 0.78 | 0.49 | 0.54 | 10.86 | 8.42 |
Net Sales Growth(%) | 20.46 | 39.14 | 34.25 | 13.93 | 0.14 | 11.88 | 27.31 | 35.51 | -5.28 | 28.09 | 19.02 |
EBIT Growth(%) | 43.71 | 26.12 | 23.92 | 17.52 | -1.52 | 7.28 | 93.5 | 50.78 | 3.63 | 55.2 | 21.36 |
PAT Growth(%) | -19.92 | 51.19 | 72.65 | 13.73 | -9.25 | 13.49 | 147.15 | 60.86 | 29.52 | 57.93 | 22.59 |
EPS Growth(%) | -21.89 | 49.21 | 71.19 | 13.73 | -10.77 | 13.7 | 147.15 | 60.86 | 29.52 | 54.15 | 22.59 |
Debt/Equity(x) | 1.77 | 1.71 | 1.21 | 1.12 | 1.03 | 0.73 | 0.48 | 0.22 | 0.13 | 0.1 | 0.07 |
Current Ratio(x) | 1.13 | 1.15 | 1.16 | 1.2 | 1.27 | 1.35 | 1.32 | 1.4 | 1.6 | 2.23 | 2.48 |
Quick Ratio(x) | 0.6 | 0.73 | 0.74 | 0.77 | 0.94 | 0.85 | 0.99 | 1.05 | 1.1 | 1.67 | 1.72 |
Interest Cover(x) | 1.93 | 2.39 | 2.79 | 3.13 | 3.17 | 3.68 | 7.46 | 12.38 | 15.58 | 39.59 | 63.64 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.02 |
# | Sep 2016 | Aug 2018 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 99.99 | 100 | 74.15 | 74.15 | 74.61 | 74.77 | 74.77 | 74.83 | 74.87 | 74.87 |
FII | 0 | 0 | 1.55 | 3.27 | 2.64 | 2.62 | 2.62 | 2.27 | 2.04 | 1.37 |
DII | 0 | 0 | 4.62 | 2.04 | 1.58 | 1.38 | 1.57 | 1.67 | 1.45 | 1.2 |
Public | 0.01 | 0 | 19.68 | 20.54 | 21.17 | 21.22 | 21.03 | 21.22 | 21.64 | 22.57 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2016 | Aug 2018 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.78 | 3.91 | 2.97 | 2.97 | 2.99 | 2.99 | 2.99 | 2.99 | 3 | 3 |
FII | 0 | 0 | 0.06 | 0.13 | 0.11 | 0.1 | 0.1 | 0.09 | 0.08 | 0.05 |
DII | 0 | 0 | 0.18 | 0.08 | 0.06 | 0.06 | 0.06 | 0.07 | 0.06 | 0.05 |
Public | 0 | 0 | 0.79 | 0.82 | 0.85 | 0.85 | 0.84 | 0.85 | 0.87 | 0.9 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.78 | 3.91 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
See More Unlisted Share Articles
You May Also Know About